Yibei Zhu

3.9k total citations
55 papers, 3.1k citations indexed

About

Yibei Zhu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yibei Zhu has authored 55 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 37 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Yibei Zhu's work include Cancer Immunotherapy and Biomarkers (25 papers), Immune Cell Function and Interaction (25 papers) and Immunotherapy and Immune Responses (18 papers). Yibei Zhu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (25 papers), Immune Cell Function and Interaction (25 papers) and Immunotherapy and Immune Responses (18 papers). Yibei Zhu collaborates with scholars based in China, United States and Sweden. Yibei Zhu's co-authors include Xueguang Zhang, Jingting Jiang, Binfeng Lu, Changping Wu, Jiemin Zhao, Qianting Yang, Ning Xu, Lujun Chen, Guangbo Zhang and Xin Gao and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Yibei Zhu

55 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yibei Zhu China 27 2.1k 1.8k 538 415 362 55 3.1k
Nadine Benhamouda France 17 1.2k 0.6× 1.3k 0.7× 1.0k 1.9× 546 1.3× 420 1.2× 36 3.0k
Ke Wu China 22 1.5k 0.7× 1.2k 0.7× 671 1.2× 257 0.6× 213 0.6× 43 2.6k
Cédric Menard France 25 1.5k 0.7× 1.3k 0.8× 468 0.9× 372 0.9× 293 0.8× 45 2.8k
Yu Kato Japan 15 1.5k 0.7× 1.8k 1.0× 472 0.9× 159 0.4× 348 1.0× 30 2.7k
Todd T. Moore United States 12 1.4k 0.7× 1.8k 1.0× 686 1.3× 319 0.8× 257 0.7× 17 2.8k
Caroline Jochéms United States 31 1.9k 0.9× 2.2k 1.2× 812 1.5× 267 0.6× 438 1.2× 83 3.4k
Yumiko Yoshioka Japan 16 2.3k 1.1× 1.3k 0.7× 517 1.0× 204 0.5× 297 0.8× 37 3.4k
Carlos Alfaro Spain 28 2.1k 1.0× 2.2k 1.3× 726 1.3× 184 0.4× 403 1.1× 57 3.7k
Colm R. Duffy United States 4 1.1k 0.6× 1.6k 0.9× 514 1.0× 127 0.3× 394 1.1× 11 2.3k
Qiyi Zhao China 19 2.0k 1.0× 1.6k 0.9× 701 1.3× 180 0.4× 258 0.7× 48 3.2k

Countries citing papers authored by Yibei Zhu

Since Specialization
Citations

This map shows the geographic impact of Yibei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibei Zhu more than expected).

Fields of papers citing papers by Yibei Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibei Zhu. The network helps show where Yibei Zhu may publish in the future.

Co-authorship network of co-authors of Yibei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yibei Zhu. A scholar is included among the top collaborators of Yibei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibei Zhu. Yibei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Hui, Lan Chen, Xiaoling Zhou, et al.. (2022). Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis. Journal of Neuroimmunology. 372. 577955–577955. 1 indexed citations
2.
Liu, Lin, Honghong He, Dan Xu, et al.. (2020). Association between interleukin‑36γ and tumor progression in non‑small cell lung cancer. Oncology Letters. 19(3). 2457–2465. 2 indexed citations
3.
Zhang, Xiaofu, et al.. (2020). Fertility preservation in BRCA mutation carriers—efficacy and safety issues: a review. Reproductive Biology and Endocrinology. 18(1). 11–11. 17 indexed citations
4.
Zheng, Xiao, Xing Song, Yingjie Shao, et al.. (2017). Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis. Oncotarget. 8(34). 57386–57398. 67 indexed citations
5.
Shi, Liangrong, Lujun Chen, Changping Wu, et al.. (2016). PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor. Clinical Cancer Research. 22(5). 1173–1184. 244 indexed citations
6.
7.
Zhang, Guangbo, Haitao Huang, Yibei Zhu, et al.. (2015). A novel subset of B7-H3+CD14+HLA-DR−/lowmyeloid-derived suppressor cells are associated with progression of human NSCLC. OncoImmunology. 4(2). e977164–e977164. 40 indexed citations
8.
Ji, Peng, et al.. (2015). [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].. PubMed. 31(6). 808–11. 9 indexed citations
9.
10.
Li, Gang, Qianting Yang, Yibei Zhu, et al.. (2013). T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells. PLoS ONE. 8(6). e67401–e67401. 57 indexed citations
11.
Xu, Haiyan, Xiaozhou He, Wei Zhao, et al.. (2012). CD256 can be found in antibody-mediated renal allograft rejection tissues.. PubMed. 58(5-6). 411–8. 5 indexed citations
12.
Gao, Xin, Yibei Zhu, Gang Li, et al.. (2012). TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression. PLoS ONE. 7(2). e30676–e30676. 342 indexed citations
13.
Chen, Lujun, Xiao Zheng, Yueping Shen, et al.. (2012). Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer. Cancer Immunology Immunotherapy. 62(3). 553–561. 72 indexed citations
14.
Yang, Qianting, Gang Li, Yibei Zhu, et al.. (2011). IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cells. European Journal of Immunology. 41(11). 3351–3360. 166 indexed citations
15.
Zhu, Yibei, Songguang Ju, Elizabeth Chen, et al.. (2010). T-bet and Eomesodermin are required for adaptive immunity against cancer (101.27). The Journal of Immunology. 184(Supplement_1). 101.27–101.27. 1 indexed citations
16.
Jiang, Jingting, Yibei Zhu, Changping Wu, et al.. (2010). Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer. Cancer Immunology Immunotherapy. 59(11). 1707–1714. 86 indexed citations
17.
Cao, Huiling, Shibing Yu, Zhi Yao, et al.. (2010). Activating transcription factor 4 regulates osteoclast differentiation in mice. Journal of Clinical Investigation. 120(8). 2755–2766. 79 indexed citations
18.
Wu, Changping, Ning Xu, Yibei Zhu, et al.. (2009). Clinical evaluation of serum alpha‐fetoprotein–IgM immune complexes on the diagnosis of primary hepatocellular carcinoma. Journal of Clinical Laboratory Analysis. 23(4). 213–218. 11 indexed citations
19.
Lü, Xiang, Bi‐Min Shi, Yibei Zhu, et al.. (2008). Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T Cells. Journal of Clinical Immunology. 28(5). 464–472. 54 indexed citations
20.
Wu, Changping, Yibei Zhu, Jingting Jiang, et al.. (2006). Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochemica. 108(1). 19–24. 421 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadine Benhamouda Breakdown of academic impact, for papers by Ke Wu Breakdown of academic impact, for papers by Cédric Menard Breakdown of academic impact, for papers by Yu Kato Breakdown of academic impact, for papers by Todd T. Moore Breakdown of academic impact, for papers by Caroline Jochéms Breakdown of academic impact, for papers by Yumiko Yoshioka Breakdown of academic impact, for papers by Carlos Alfaro Breakdown of academic impact, for papers by Colm R. Duffy Breakdown of academic impact, for papers by Qiyi Zhao
Rankless by CCL
2026